http://polyscience.org/2005/07/asthma-knee-jerk/ Mon, 08 Mar 2010 03:15:32 +0000 hourly 1 http://wordpress.org/?v=3.0 http://polyscience.org/2005/07/asthma-knee-jerk/comment-page-1/#comment-13 polyscience.org » Advair, Serevent, and Foradil to remain on the market Wed, 20 Jul 2005 14:05:12 +0000 http://polyscience.org/?p=10#comment-13 [...] As a followup to last Wednesday’s post the panel assembled to ascertain whether or not Serevent, Advair, and Foradil should remain on the market voted unanimously to keep the three drugs available, citing an acceptable risk/benefit ratio. The panel also did not recommend any changes to the products or their packaging. This is good news for the estimated 20 million asthma sufferers in the United States. [...] [...] As a followup to last Wednesday’s post the panel assembled to ascertain whether or not Serevent, Advair, and Foradil should remain on the market voted unanimously to keep the three drugs available, citing an acceptable risk/benefit ratio. The panel also did not recommend any changes to the products or their packaging. This is good news for the estimated 20 million asthma sufferers in the United States. [...]

]]>